Andrea Newkirk

Stock Analyst at Goldman Sachs

(2.92)
# 1,679
Out of 5,055 analysts
4
Total ratings
100%
Success rate
37.57%
Average return

Stocks Rated by Andrea Newkirk

Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $17.64
Upside: +7.71%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65$73
Current: $67.75
Upside: +7.75%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $29.04
Upside: +48.07%